B7-H4 is over-expressed in early-stage ovarian cancer and is independent of CA125 expression (Q34627880)

3 August 2017

title

B7-H4 is over-expressed in early-stage ovarian cancer and is independent of CA125 expression (English)

1 reference

3 August 2017

1 reference

Eleftherios P. Diamandis

9

object named as

Eleftherios P Diamandis

1 reference

3 August 2017

Andreas Scorilas

5

0 references

Dionyssios Katsaros

2

object named as

Dionyssios Katsaros

1 reference

3 August 2017

Iris Simon

1

1 reference

3 August 2017

Irene Rigault de la Longrais

3

1 reference

3 August 2017

Marco Massobrio

4

1 reference

3 August 2017

Nam W Kim

6

1 reference

3 August 2017

Mark J Sarno

7

1 reference

3 August 2017

Robert L Wolfert

8

1 reference

3 August 2017

language of work or name

English

0 references

publication date

11 May 2007

1 reference

3 August 2017

1 reference

3 August 2017

volume

106

1 reference

3 August 2017

issue

2

1 reference

3 August 2017

page(s)

334-341

1 reference

Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.035

The performance of screening tests for ovarian cancer: results of a systematic review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.035

The efficacy of transvaginal sonographic screening in asymptomatic women at risk for ovarian cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.035

Usefulness of mass screening for ovarian carcinoma using transvaginal ultrasonography.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.035

Ovarian cancer screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial: Findings from the initial screen of a randomized trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.035

Calculation of the risk of ovarian cancer from serial CA-125 values for preclinical detection in postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.035

New tumor markers: CA125 and beyond.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.035

The immunomodulatory protein B7-H4 is overexpressed in breast and ovarian cancers and promotes epithelial cell transformation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.035

B7-h4 is highly expressed in ductal and lobular breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.035

B7-H4 overexpression in ovarian tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.035

B7-H4 Is a Novel Membrane-Bound Protein and a Candidate Serum and Tissue Biomarker for Ovarian Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.035

B7x: a widely expressed B7 family member that inhibits T cell activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.035

B7-H4, a molecule of the B7 family, negatively regulates T cell immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.035

The B7 family of immune-regulatory ligands

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.035

A method of comparing the areas under receiver operating characteristic curves derived from the same cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.035

Potential markers that complement expression of CA125 in epithelial ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.035

Blood and urine markers for ovarian cancer: a comprehensive review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.035

Role of B7-H1 and B7-H4 molecules in down-regulating effector phase of T-cell immunity: novel cancer escaping mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.035

Immunofluorometric quantitation and histochemical localisation of kallikrein 6 protein in ovarian cancer tissue: a new independent unfavourable prognostic biomarker

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.035

Human kallikrein 8 protein is a favorable prognostic marker in ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.035

The emerging roles of human tissue kallikreins in cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.035

Cellular distribution of human tissue kallikreins: immunohistochemical localization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.035

Combining CA 125 and SMR serum markers for diagnosis and early detection of ovarian carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.035

Preoperative sensitivity and specificity for early-stage ovarian cancer when combining cancer antigen CA-125II, CA 15-3, CA 72-4, and macrophage colony-stimulating factor using mixtures of multivariate normal distributions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.035

10.1016/J.YGYNO.2007.03.035

7 January 2021

Identifiers

DOI

1 reference

3 August 2017

1 reference